Bristol-Myers Squibb (NY:BMY)

65.31 +0.45 (+0.69%)

Official Closing Price Updated: 7:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Price and Volume

Volume	14,579,737
Open	65.00
Bid (Size)	65.34 (200)
Ask (Size)	65.38 (300)
Prev. Close	64.86
Today's Range	63.53 - 65.66
52wk Range	42.52 - 65.66
Shares Outstanding	2,222,113,553
Dividend Yield	3.86%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook

Today 1:36 EDT

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 5.7% year on ...

Via StockStory

Bristol-Myers Squibb (BMY) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Growth portfolio now drives 60% of revenue as Eliquis surges 21%.

Via The Motley Fool

Performance

YTD	+22.2%	+22.2%
1 Month	+13.3%	+13.3%
3 Month	+7.8%	+7.8%
6 Month	+20.3%	+20.3%
1 Year	+42.0%	+42.0%

More News

Why Bristol Myers Squibb Stock Topped the Market on Thursday ↗

July 30, 2026

Via The Motley Fool

Bristol-Myers Squibb (NYSE:BMY) Surges on Q2 Earnings Beat, Raises Full-Year Guidance ↗

July 30, 2026

Via Chartmill

Bristol Myers Squibb Co (NYSE:BMY): A High Yield Dividend Stock Backed by Strong Profitability ↗

July 18, 2026

Via Chartmill

Johnson & Johnson Just Got FDA Clearance for Its Surgical Robot, Hiked Its Dividend for the 64th Time, and Is Targeting $100 Billion in Revenue. But Here's What Investors Should Be Most Excited About ↗

July 30, 2026

Via The Motley Fool

Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales

July 30, 2026

Via StockStory

Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

July 30, 2026

From Bristol Myers Squibb

Via Business Wire

Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q2 Results Tomorrow

July 28, 2026

Via StockStory

This Healthcare Leader Just Made a Bet on Artificial Intelligence (AI): Time to Buy the Stock? ↗

July 28, 2026

Via The Motley Fool

My 3 Favorite Artificial Intelligence (AI) Stocks to Buy Right Now ↗

July 28, 2026

Via The Motley Fool

Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now ↗

July 27, 2026

Via MarketBeat

Israel "Izzy" Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn't? ↗

July 26, 2026

Via The Motley Fool

Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer ↗

July 24, 2026

Via The Motley Fool

3 Healthcare Stocks We Keep Off Our Radar

July 24, 2026

Via StockStory

BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring ↗

July 23, 2026

Via The Motley Fool

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

July 20, 2026

From Bristol Myers Squibb

Via Business Wire

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb ↗

July 14, 2026

Via The Motley Fool

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

July 13, 2026

From Bristol Myers Squibb

Via Business Wire

2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now ↗

July 07, 2026

Via The Motley Fool

3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List) ↗

July 07, 2026

Via The Motley Fool

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know. ↗

July 06, 2026

Via The Motley Fool

Vanguard Is Bullish on Value Stocks and Fixed Income. Are These 2 ETFs a Good Buy? ↗

July 05, 2026

Via The Motley Fool

2 Cash-Producing Stocks Worth Investigating and 1 Facing Headwinds

July 03, 2026

Via StockStory

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 01, 2026

Via The Motley Fool

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?

Yes, Bristol-Myers Squibb is publicly traded.

What exchange does Bristol-Myers Squibb trade on?

Bristol-Myers Squibb trades on the New York Stock Exchange

What is the ticker symbol for Bristol-Myers Squibb?

The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange

What is the current price of Bristol-Myers Squibb?

The current price of Bristol-Myers Squibb is 65.31

When was Bristol-Myers Squibb last traded?

The last trade of Bristol-Myers Squibb was at 07/31/26 07:00 PM ET

What is the market capitalization of Bristol-Myers Squibb?

The market capitalization of Bristol-Myers Squibb is 145.13B

How many shares of Bristol-Myers Squibb are outstanding?

Bristol-Myers Squibb has 145B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.